Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta‐analysis

Background Although radiofrequency ablation is widely used in the treatment of arrhythmias, its role in septal reduction therapy of hypertrophic obstructive cardiomyopathy (HOCM) is unclear. This meta‐analysis aimed to assess the efficacy and safety of radiofrequency septal ablation for HOCM. Hypoth...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cardiology (Mahwah, N.J.) Vol. 43; no. 5; pp. 450 - 458
Main Authors: Yang, Haonan, Yang, Yuan, Xue, Yuzhou, Luo, Suxin
Format: Journal Article
Language:English
Published: New York Wiley Periodicals, Inc 01.05.2020
John Wiley & Sons, Inc
Subjects:
Ablation
Aged
Cardiomyopathy
Cardiomyopathy, Hypertrophic - physiopathology
Cardiomyopathy, Hypertrophic - surgery
Catheters
Echocardiography - methods
Edema
Female
Humans
hypertrophic obstructive cardiomyopathy
Male
Meta-analysis
Middle Aged
Patients
radiofrequency ablation
Radiofrequency Ablation - methods
Review
Reviews
septal reduction therapy
Statistical analysis
Studies
Surgery, Computer-Assisted - methods
Systematic review
Treatment Outcome
meta-analysis
septal reduction therapy
hypertrophic obstructive cardiomyopathy
radiofrequency ablation
ISSN:0160-9289, 1932-8737, 1932-8737
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Although radiofrequency ablation is widely used in the treatment of arrhythmias, its role in septal reduction therapy of hypertrophic obstructive cardiomyopathy (HOCM) is unclear. This meta‐analysis aimed to assess the efficacy and safety of radiofrequency septal ablation for HOCM. Hypothesis Radiofrequency septal ablation is effective and safe for relieving obstruction and improving exercise capacity in patients with HOCM. Methods A systematic review of eligible studies that reported outcomes of patients with HOCM who underwent radiofrequency septal ablation was performed using PubMed, Embase, Cochrane, ProQuest, Scopus, ScienceDirect, and Web of Science database. Pooled estimates were calculated using random‐effects meta‐analysis. Methodological quality was assessed using the Newcastle‐Ottawa scale. Publication bias and sensitivity analyses were also performed. Results Eight studies with 91 patients (mean follow‐up 11.6 months) were included. The left ventricular outflow tract (LVOT) gradient at rest decreased significantly after radiofrequency septal ablation (pooled reduction: −58.8 mmHg; 95% confidence interval [CI] −64.3 to −53.5). A reduction was also found in the provoked LVOT gradient with a pooled reduction of −97.6 mmHg (95% CI: −124.4 to −87.1). An improvement of the New York Heart Association classification (mean: −1.4; 95% CI: −1.6 to −1.2) was found during follow‐up. The change in septal thickness was minimal and not statistically significant. Two procedure‐related deaths were documented, and complete heart block occurred in eight patients. Conclusions Radiofrequency septal ablation is effective and safe for relieving LVOT obstruction and improving exercise capacity in patients with HOCM.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Haonan Yang and Yuan Yang contributed equally to this work.
ISSN:0160-9289
1932-8737
1932-8737
DOI:10.1002/clc.23341